The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men

Journal of the American Medical Association

Volumn 288, Issue 21, 2002, Pages 2709-2716

  Lakka, Hanna Maaria ^a,b   Laaksonen, David E ^b,c   Lakka, Timo A ^a,b   Niskanen, Leo K ^c   Kumpusalo, Esko ^b,c   Tuomilehto, Jaakko ^e,f   Salonen, Jukka T ^b,d  

^a PENNINGTON BIOMEDICAL RESEARCH CENTER   (United States)

^b UNIVERSITY OF EASTERN FINLAND   (Finland)

^c KUOPIO UNIVERSITY HOSPITAL   (Finland)

^d Inner Savo Health Centre   (Finland)

^e UNIVERSITY OF HELSINKI   (Finland)

^f NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CONFIDENCE INTERVAL; FACTORIAL ANALYSIS; FOLLOW UP; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; MORTALITY; PRIORITY JOURNAL; RISK FACTOR; VARIANCE; WORLD HEALTH ORGANIZATION;

EID: 0037021505     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.288.21.2709     Document Type: Article

References (42)

1. Reaven GM. Banting lecture 1988: Role of insulin resistance in human disease. Diabetes. 1988;37:1595-1607.
2. Liese AD, Mayer-Davis EJ, Haffner SM. Development of the multiple metabolic syndrome: An epidemiologic perspective. Epidemiol Rev. 1998;20:157-172.
3. Bouchard C. Genetics and the metabolic syndrome. Int J Obes Relat Metab Disord. 1995; 19 (suppl 1):S52-S59.
4. Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications, I: Diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med. 1998;15:539-553.
5. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA. 2001;285:2486-2497.
6. Obesity: Preventing and Managing the Global Epidemic: Report of a WHO Consultation. Geneva, Switzerland: World Health Organization; 2000. WHO Technical Report Series, 894.
7. Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults: Findings from the third National Health and Nutrition Examination Survey. JAMA. 2002;287:356-359.
8. Isomaa B, Almgren P, Tuomi T, et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care. 2001;24:683-689.
9. Haffner SM, Lehto S, Rönnemaa T, Pyörälä K, Laakso M. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med. 1998;339:229-234.
10. Grundy SM, Benjamin IJ, Burke GL, et al. Diabetes and cardiovascular disease: A statement for healthcare professionals from the American Heart Association. Circulation. 1999;100:1134-1146.
11. Smith SC Jr, Blair SN, Bonow RO, et al. AHA/ACC Guidelines for Preventing Heart Attack and Death in Patients With Atherosclerotic Cardiovascular Disease: 2001 Update: A statement for healthcare professionals from the American Heart Association and the American College of Cardiology. J Am Coll Cardiol. 2001;38:1581-1583.
12. Selby JV, Newman B, Quiroga J, et al. Concordance for dyslipidemic hypertension in male twins. JAMA. 1991;265:2079-2084.
13. Castelli WP. Epidemiology of coronary heart disease: The Framingham study. Am J Med. 1984;76:4-12.
14. Salonen JT. Is there a continuing need for longitudinal epidemiologic research? the Kuopio Ischaemic Heart Disease Risk Factor Study. Ann Clin Res. 1988;20:46-50.
15. Lakka HM, Lakka TA, Tuomilehto J, Sivenius J, Salonen JT. Hyperinsulinemia and the risk of cardiovascular death and acute coronary and cerebrovascular events in men: The Kuopio Ischaemic Heart Disease Risk Factor Study. Arch Intern Med. 2000;160: 1160-1168.
16. Laaksonen DE, Lakka HM, Salonen JT, et al. The metabolic syndrome and development of diabetes mellitus: Application and validation of recently suggested definitions of the metabolic syndrome in a prospective cohort study. Am J Epidemiol. In press.
17. Balkau B, Charles MA. Comment on the provisional report from the WHO consultation: European Group for the Study of Insulin Resistance (EGIR). Diabet Med. 1999;16:442-443.
18. The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure. Arch Intern Med. 1997;157: 2413-2446.
19. 1999 World Health Organization-International Society of Hypertension Guidelines for the Management of Hypertension: Guidelines Subcommittee. J Hypertens. 1999;17:151-183.
20. Lakka TA, Venäläinen JM, Rauramaa R, et al. Relation of leisure-time physical activity and cardiorespiratory fitness to the risk of acute myocardial infarction. N Engl J Med. 1994;330:1549-1554.
21. Salonen JT, Nyyssönen K, Korpela H, et al. High stored iron levels are associated with excess risk of myocardial infarction in eastern Finnish men. Circulation. 1992;86:803-811.
22. Lynch J, Helmrich SP, Lakka TA, et al. Moderately intense physical activities and high levels of cardiorespiratory fitness reduce the risk of non-insulindependent diabetes mellitus in middle-aged men. Arch Intern Med. 1996;156:1307-1314.
23. Tuomilehto J, Sarti C, Narva EV, et al. The FINMONICA Stroke Register: Community-based stroke registration and analysis of stroke incidence in Finland, 1983-1985. Am J Epidemiol. 1992;135:1259-1270.
24. Tuomilehto J, Arstila M, Kaarsalo E, et al. Acute myocardial infarction (AMI) in Finland - Baseline data from the FINMONICA AMI register in 1983-1985. Eur Heart J. 1992;13:577-587.
25. WHO MONICA Project. MONICA Manual, Part IV: Event Registration. Available at: http://www.ktl.fi/publications/monica/manual/index.htm. Accessed September 22, 2002.
26. Lakka HM, Lakka TA, Tuomilehto J, Salonen JT. Abdominal obesity is associated with increased risk of acute coronary events in men. Eur Heart J. 2002;23: 706-713.
27. Cureton EE, D'Agostino RB. Factor Analysis: An Applied Approach. Hillsdale, NJ: Lawrence Erlbaum Associates; 1983.
28. Stevens J. Applied Multivariate Statistics for the Social Sciences. Hillsdale, NJ: Lawrence Erlbaum Associates; 1986.
29. Meigs JB. Invited commentary: Insulin resistance syndrome? syndrome X? multiple metabolic syndrome? a syndrome at all? factor analysis reveals patterns in the fabric of correlated metabolic risk factors [discussion Am J Epidemiol. 2000;152:912]. Am J Epidemiol. 2000;152:908-911.
30. Lahti-Koski M, Pietinen P, Männistö S, Vartiainen E. Trends in waist-to-hip ratio and its determinants in adults in Finland from 1987 to 1997. Am J Clin Nutr. 2000;72:1436-1444.
31. Lahti-Koski M, Jousilahti P, Pietinen P. Secular trends in body mass index by birth cohort in eastern Finland from 1972 to 1997. Int J Obes Relat Metab Disord. 2001;25:727-734.
32. Edwards KL, Austin MA, Newman B, et al. Multivariate analysis of the insulin resistance syndrome in women. Arterioscler Thromb. 1994;14:1940-1945.
33. Pyörälä M, Miettinen H, Halonen P, Laakso M, Pyörälä K. Insulin resistance syndrome predicts the risk of coronary heart disease and stroke in healthy middle-aged men: The 22-year follow-up results of the Helsinki Policemen Study. Arterioscler Thromb Vasc Biol. 2000;20:538-544.
34. Meigs JB, D'Agostino RB Sr, Wilson PW, et al. Risk variable clustering in the insulin resistance syndrome: The Framingham Offspring Study. Diabetes. 1997;46: 1594-1600.
35. Lempiäinen P, Mykkänen L, Pyörälä K, Laakso M, Kuusisto J. Insulin resistance syndrome predicts coronary heart disease events in elderly nondiabetic men. Circulation. 1999;100:123-128.
36. Tuomilehto J, Lindström J, Eriksson JG, et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med. 2001;344:1343-1350.
37. Knowler WC, Barrett-Connor E, Fowler SE, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med, 2002; 346:393-403.
38. Physical Activity and Health: A Report of the Surgeon General. Atlanta, Ga: US Dept of Health and Human Services, Centers for Disease Control, National Center for Chronic Disease Prevention and Health Promotion; 1996.
39. Jenkins DJ, Axelser M, Kendall CW, et al. Dietary fibre, lente carbohydrates and the insulin-resistant diseases. Br J Nutr. 2000;83(suppl 1):S157-S163.
40. Vessby B, Uusitupa M, Hermansen K, et al. Substituting dietary saturated for monounsaturated fat impairs insulin sensitivity in healthy men and women: The KANWU Study. Diabetologia. 2001;44:312-319.
41. Summers LK, Fielding BA, Bradshaw HA, et al. Substituting dietary saturated fat with polyunsaturated fat changes abdominal fat distribution and improves insulin sensitivity. Diabetologia. 2002;45:369-377.
42. Laaksonen DE, Lakka HM, Salonen JT, et al. Low levels of leisure-time physical activity and cardiorespiratory fitness predict development of the metabolic syndrome. Diabetes Care. 2002;25:1612-1618.